A cancer diagnosis has the potential to throw your entire life into disarray, impacting both your physical and mental wellbeing. At SurvivorNet, we believe treating the whole person is imperative, so ...

Radiation therapy is a cornerstone in the treatment of many gliomas, particularly when used alongside surgery and sometimes chemotherapy. Each patient’s treatment is customized based on the tumor’s ...

Dr. Juan Pablo Ospina offers guidance to help glioma patients understand their condition and navigate treatment. He advises working closely with a team of specialists, tailoring therapy to individual ...

When an MRI or CT scan shows a suspicious mass in the brain, your medical team may recommend a brain biopsy. A biopsy is a procedure where a small piece of tissue is removed so a pathologist can look ...

With better surgery, smarter imaging, and targeted drugs like IDH inhibitors, the story of low-grade glioma is increasingly one of long-term disease management. Still, any glioma diagnosis is ...

A new FDA-approved treatment for HER2-positive metastatic breast cancer—trastuzumab deruxtecan (Enhertu) in combination with pertuzumab (Perjeta)—has prompted excitement among experienced breast ...

U.S. Air Force Chief Master Sergeant and breast cancer survivor Chanda Conger found hope in small coins—pennies that reminded her of her late father—during her cancer journey. Diagnosed at 38, she ...

Joel Gendron, a father and brain tumor survivor, is sharing his journey after being diagnosed with a grade 2 glioma, undergoing surgery, chemotherapy, and radiation. He emphasizes the importance of ...

After being diagnosed with a rare brain tumor, Joel Gendron focused on showing his children strength, optimism, and his same quirky self to reassure them he would be okay. Gendron was diagnosed with a ...

For patients facing low-grade glioma, the targeted drug vorasidenib has emerged as a milestone treatment option. It is the first systemic therapy specifically for people with certain gliomas with ...

A recurrence doesn’t mean you have “run out” of treatment options. For most people with grade 2 glioma that has an IDH mutation, regrowth is expected eventually, and it’s a signal to turn the page to ...

Dr. Nick Gonzalez Castro, a neurologist and neuro-oncologist at the Dana-Farber Cancer Institute within Brigham and Women’s Hospital, feels privileged to work in Boston, Massachusetts, and to treat ...